This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research. The National University of Singapore (NUS) is home to 32 Highly Cited Researchers in 2021.
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
This is going to lead to a lot of health problems and associated costs. Data from the Kaiser Family Foundation (KFF) shows that between 2011 and 2021, the average premiums for family coverage rose from $15,073 to $22,221—an increase of 47.4%. 1ne: A new analysis predicts that by 2030, 48.9% will be severely obese. percent of U.S.
However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. 2021 Sales Hiring in Review. At the end of 2021, there were 4.3M
The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%
As a medical sales professional looking ahead to 2021, now more than ever it is imperative to evaluate your strategy for the new year. Here are 21 tips to grow your medical sales business in 2021: 21 – Understand Pain Points. What their pain points may have been at the beginning of 2020 are most certainly going to be different in 2021.
2 Modified CDs have higher solubility and even substitution with hydrophobic side groups leads to improved solubility. When a pH range is defined, a buffer is normally used to stabilise the pH in this range – if possible, this buffer should be selected to have no interaction with the CD, as this would form a competitive complexation.
Selling has become increasingly competitive. Only 60% of sales teams and reps hit their annual quotas in recent years, and 69% of sales professionals agree their job is harder now than it was in 2021. Simply learning how to find, approach and engage new customers is at the heart of being able to meet and exceed your sales goals.
The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.
What are the traits of a great salesperson in 2021? Here’s something world class sales organization understand: Especially in B2B sales, establishing your competitive advantage is often less about your solutions and more about the day-to-day actions of your sales professionals. Best Practices of World Class Sales Organizations.
Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .
The US was found to be the leading country within the industry and has one of the highest growth scores in the survey’s history. Competitiveness. India has built on its 2021 gains with a huge 15 percent improvement. Key countries. Germany (in second place) and the UK achieved double-digit growth. Finished Dosage.
Highly Cited Researchers 2021 are based at more than 1,300 institutions. The Highly Cited Researchers campaign is an opportunity to introduce Korea University’s research competitiveness to our audience.”. We think Highly Cited Researchers are the most influential researchers leading in their fields.
ON 11 JANUARY 2022, Regulation (EU) 2021/2282 on health technology assessment (HTA) came into force. Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. Official Journal of the European Union; 2021. References.
In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.
billion in 2021, with a compounded annual growth rate (CAGR) of 3.1% However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles.
This pressure is leading to increased base salaries. It also means that employers face the most competitive, candidate-driven employment market in history. Looking to 2021 and beyond, there are two factors that will intensify the battle for sales talent. To combat this, employers must utilize a three-pronged approach.
AB Science has secured a Canadian patent for its lead compound masitinib to treat amyotrophic lateral sclerosis (ALS), a fatal motor neuron disorder. This helps to prevent generic competition for eight years after initial approval. AB Science said that masitinib is also eligible for regulatory data protection in the country.
GlobalData’s Internet of Things (IoT) Market report helps keep abreast of the latest trends in internet of things, market opportunity forecast and the competitive landscape. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.
These are forecast to generate $264 billion in sales between 2021 and 2028. Comirnaty, which was first approved in the UK by an Emergency Use Approval (EUA) from the Medicines and Healthcare products Regulatory Agency (MHRA) on December 2, 2020, is currently the leading prophylactic vaccine with 2021 sales of $41.5
In sales, where rejection is a part of the job even in the best of times and today’s selling environment has grown more stressful, competitive and demanding, signs of burnout are becoming more common across the profession. In 2021, 40% of employees cited burnout as the top reason for leaving. Britt Andreatta, Ph.D.,
However, patient uptake hasn’t matched rising market competition. Among surveyed patients, nearly half (47%) couldn’t remember a single preventive migraine brand name, and the leading brand patients did recall— Topamax —is an older drug that was approved for migraine in 2004. What Marketers Can Do.
Following initial consultations in 2021, we expect the publication of the proposal for changes to the EU’s pharmaceutical legislation and potential adoption by the European Commission (EC) by December 2022. He focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe.
Our team connected with marketing and strategy leaders across dozens of leading healthcare organizations at SHSMD’s Annual Connections Conference. This is crucial for systems looking to stay competitive in today’s market, where high acuity cases are tending to leave hospital ORs and migrate to ASCs.
Adopting the following six marketing strategies may help you stay competitive, bring in new patients, and grow your practice substantially. With a well-thought-out and executed plan, you can be in a better position to outperform your competition. 6 Medical Marketing Strategies to Adopt in 2023. Create a Strong Social Media Presence.
Research by Treasure Data , a market leading enterprise customer data platform (CDP), shows that HCPs are increasingly turning to digital to research scientific information, new medications, and brands. billion in 2021 to $9.23 If you have to wait to extract meaning from your data then you won’t be competitive enough. “A
“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% Novo Nordisk is another company leading the charge in this field. weight loss in obese or overweight individuals.
in 2021, while Original Medicare enrollment fell by 2.6%. Aetna, Centene, and UnitedHealth Group currently lead the market with the most year-over-year growth. In 2022, there was an 8% increase in the number of Medicare Advantage plans available to consumers, further heightening the high-growth, competitively surged market.
In 2021, the FDA granted Amgen’s (NASDAQ:AMGN) non-small cell lung cancer (NSCLC) drug Lumakras (sotorasib) an expedited approval, making it the first FDA-approved KRAS inhibitor. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov.
In 2021, Mercer evaluated over 280 high-quality provider networks across 97 markets using Clarify Networks , a cloud analytics software that uses AI and machine learning to optimize network quality, efficiency, and referral patterns. It will help enable competitive coverage for Mercer’s clients so that employees have greater access to care.
2021 launched a new era for healthcare price transparency. In January 2021, the Healthcare Price Transparency Act went into effect, requiring hospitals to publish their cash pay rates and rates negotiated with health insurance companies.
In recent years significant improvements in automation of cell line development have reduced timelines for demonstrating productivity and clonality of lead cell lines from months to weeks. Using this data, it was possible to select a lead cell line that was scalable and produced 8 g/l across 15ml to 200l (see Figure 2 ).
“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% Novo Nordisk is another company leading the charge in this field. weight loss in obese or overweight individuals.
Make sure that you examine not just when and where inbound and outbound leads convert, but also how your teams prospected with these clients, and which tactics were most successful. This helps ensure reps are only engaging prospects with the highest likelihood of converting into a qualified lead. Set Minimum Daily Sales Activities.
March 9, 2021 Critical to optimizing sales force productivity and efficiency is identifying the right HCP and/or account targets. However, if all products in the market are chasing the largest segment of that market, then this segment consequentially becomes the most competitive.
The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities. DMD pathology is caused by a lack of dystrophin protein, leading to the weakening and damage of muscle cells progressively over time. Free Report How is the Biopharmaceutical industry evolving?
Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. Today, the Dialog Solutions brand has been integrated into Clarivate.
Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati’s adagrasib as Krazati for a form of lung cancer. Analysts have suggested, however, that the profile of the two drugs is very similar, leading to questions about how successful Mirati will be differentiating Krazati from its rival.
In fact, the pharmaceutical industry’s development pipeline has reached an all-time high of 20,109 products under active development at the end of January 2022, an increase of 500 from 2021. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals.
The European Commission (EC) conducted a comprehensive assessment 1 in 2021 that revealed that 80 percent of API by volume imported into Europe comes from just five countries, with China supplying 45 percent of the API and the rest coming from India, Indonesia, US and UK.
The Centers for Medicare and Medicaid Services (CMS) tried to tackle this problem through its price transparency rules, which went into effect for hospitals in 2021 and health plans in 2023. Dig deeper into strategies for hospital growth and differentiation in competitive markets in our 2023 Growth Playbook.
As we mentioned earlier, nearly three in four doctors now work for a hospital, health system, or corporate entity, according to an April 2022 survey from Avalere Health —a 7% increase from 2021 and a nearly 20% jump from 2019. This step is particularly crucial in an era where new competition enters the market every day.
Moreover, we’ll shed light on the evolution of medical sales techniques and strategies, the impact of technology, and the importance of talent acquisition to thrive in this competitive domain. Attracting and Retaining Top Sales Talent A competitive compensation package is just the beginning.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content